Skip to content

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Please ensure you fully understand the risks involved. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Please ensure you fully understand the risks involved.

Top 10 ASX growth stocks to watch in February 2025

Read on for an overview of growth stocks, why they’re special, and a list of the top 10 ASX growth stocks in February 2025, selected based on recent market news and ranked by the largest share price return over the past 3 months.

asx growth shares Source: Getty

What is an ASX growth stock?

Growth stocks are shares in companies that are expected to grow much faster than a company's average growth within the wider market or within its specific sector.

Instead of paying dividends, any profits generated are ploughed back into the business to help accelerate growth. Accordingly, investors usually hope to profit from capital gains in the short term, with dividend income a potential outcome once major growth has been established.

Some of the best growth stocks, especially those in a specialist niche, trade at a high price-to-earnings ratio. Therefore, would-be investors usually pay a premium in the hope of future growth. However, growth stocks can see rapid declines if the company underperforms, even in just one quarter.

Common traits of the most popular ASX growth stocks often include holding patents or technologies that grant the company a unique marketplace advantage. Therefore, many have a loyal customer base and disproportionately high market share.

One key misunderstanding is that all growth stocks are small caps that have weaker financials or are confined to domestic business. While many are, larger companies can qualify as growth stocks depending on how much market share remains available.

As an extreme example, the US$570 billion market titan Tesla is still a growth stock, delivering less than one million of the 66.7 million automobiles sold in 2021.

Growth Stocks: high risk, high reward?

One of the best-known rules of investing is the risk-reward ratio, whereby investors balance an equilibrium in which higher-risk companies deliver either negative capital growth or far better rewards than value or income investing.

For context, penny stock investing is generally regarded as very high-risk but with the potential for exceptional returns.
Conversely, income stock investing through blue chip companies for dividends is relatively low risk, but returns can take years to become meaningful.

ASX growth stocks take their place somewhere in the middle. Of course, many investors

choose to invest in a diversified portfolio that includes multiple different growth stocks to account for the risk of an individual failure. And in this recessionary environment, it can make sense to buy the dip slowly through dollar-cost averaging to further mitigate the chances of losing capital.

Fundamentally, all investing comes with risk. Tesla proponents believe the EV trailblazer could one day become the automobile production market leader. However, any threat to this goal through competition or similar could cause a sharp correction in the future. Conversely, if Tesla succeeds, its future market cap may make the current valuation look small.

Another common growth stock example is biotech companies, some of whose valuations are underpinned by one drug or treatment. If the drug fails in the trial stages, the share price can collapse, as has happened to Synairgen, BridgeBio Pharma, Sensorion, and Rafael, among countless others.

What makes ASX growth stocks special right now?

Right now, ASX growth stocks are stealing the spotlight thanks to their resilience and ability to harness long-term global trends. Even as high interest rates and cautious consumer spending weigh on the broader economy, these stocks stand out for their innovation, strong fundamentals, and alignment with today’s most essential sectors.

Thriving in technology

Australia’s tech sector is currently a major draw for investors, with companies like Xero and TechnologyOne showing impressive growth.

Xero, an accounting software provider for small and medium businesses, has built a loyal customer base by saving users hours of manual work weekly. This has made its services indispensable, especially as businesses increasingly rely on digital solutions.

Similarly, TechnologyOne offers enterprise software that helps organisations streamline their operations. Both companies have demonstrated the kind of steady, recurring revenue that gives them resilience in challenging economic climates.

Healthcare innovation

The healthcare and biotech sectors are also thriving, driven by innovation and global demand.

Mesoblast, a leader in regenerative medicine, is advancing its therapies for conditions like chronic heart failure. This reflects the sector’s ability to address critical health challenges, making it less tied to economic cycles and highly appealing to long-term investors.

Retail resilience

The consumer space, particularly premium retail, is another area piquing investor interest. Jewellery retailer Lovisa continues to expand internationally – building on its established reputation and solid growth history. Despite a pullback in discretionary spending, Lovisa’s global strategy and innovative approach have positioned it as a leader in its niche.

Driving the clean energy future

Sustainability-focused companies are booming as the world transitions to cleaner energy.

For instance, Battery Minerals recently saw its share price soar, reflecting growing optimism about its role in the development of materials essential for renewable energy technologies. These stocks are aligning themselves with the global push for decarbonisation, making them a pivotal part of future-focused portfolios.

Opportunities for value

Recent market corrections have left many growth stocks trading at more attractive valuations, making this an opportune time for savvy investors. As interest rates stabilise, these companies are positioned to deliver significant returns – particularly those in sectors like tech, healthcare, and sustainability that are driving global transformation.

With their ability to innovate, adapt, and lead in transformative industries, ASX growth stocks represent a compelling opportunity for investors looking to the future.

With that in mind, here is a list of ten ASX growth stocks for investors to consider.

Remember, past performance is not an indicator of future returns.

Top 10 ASX growth stocks to watch

These shares have been selected due to their substantial share price returns over the past three months. While they may not necessarily represent the best long-term growth investments, they have garnered significant investor interest.

Petratherm (ASX: PTR)

Petratherm is a geothermal energy company focused on developing sustainable, zero-emission power solutions. Recently, its share price has skyrocketed, driven by renewed investor interest in clean energy and the company’s promising projects. As global energy markets shift towards renewables, Petratherm’s innovative approach to harnessing geothermal energy has positioned it as a standout growth stock on the ASX.

A key driver behind its recent success has been growing enthusiasm for green energy investments and advancements in its geothermal exploration efforts. Petratherm’s South Australian projects, particularly its early-stage heat energy initiatives, have caught the attention of investors seeking exposure to sustainable power solutions. With government policies increasingly favouring renewable energy development, the company is well-placed for future expansion.

With the world’s energy transition accelerating, investors looking for high-growth opportunities in the clean energy sector may find Petratherm an attractive prospect. If the company can continue to deliver progress on its geothermal projects, its recent momentum could be just the beginning of a longer-term upward trend.

Petratherm has achieved a 720% share price return over the last three months.

Market cap: $120.59 million.

AusQuest Ltd (ASX: AQD)

AusQuest is a mineral exploration company focused on discovering high-value base and precious metal deposits across Australia and Peru. The company’s recent surge in share price reflects growing optimism around its exploration prospects – particularly its copper and nickel projects. With global demand for these essential metals rising due to their use in electric vehicles and clean energy infrastructure, AusQuest is well-positioned to benefit.

Investor excitement has been fuelled by promising drilling results and strategic partnerships, including agreements with major industry players to advance its projects. AusQuest’s ability to secure funding and collaborations with larger mining companies has strengthened its growth trajectory, making it a compelling ASX growth stock to watch.

As the demand for critical minerals intensifies, companies with well-located and high-potential projects like AusQuest could see sustained interest. Investors keeping an eye on ASX growth stocks may find this explorer’s progress worth tracking.

AusQuest Ltd has achieved a 333.3% share price return over the last three months.

Market cap: $36.92 million.

Alterity Therapeutics (ASX: ATH)

Alterity Therapeutics is a biotechnology company focused on developing novel treatments for neurodegenerative diseases, including Parkinson’s. Its remarkable share price surge is largely attributed to recent breakthroughs in its research pipeline, particularly its lead drug candidate ATH434, which has shown promise in early-stage trials.

The company has gained traction following positive preclinical data, strong intellectual property protection, and increasing interest from the medical community. With neurodegenerative conditions affecting millions worldwide and limited treatment options available, Alterity’s innovative approach to tackling these diseases has made it a standout ASX growth stock.

For investors seeking exposure to the high-risk, high-reward biotech sector, Alterity Therapeutics represents a stock with significant upside potential – particularly if its clinical trials continue to deliver positive results.

Alterity Therapeutics has achieved a 300% share price return over the last three months.

Market cap: $69.16 million.

Thrive Tribe Technologies (ASX: 1TT)

Thrive Tribe Technologies operates in the technology and cybersecurity space, providing solutions aimed at protecting businesses and individuals from cyber threats. Its dramatic share price increase has been driven by growing investor interest in cybersecurity, an industry that continues to expand as digital security becomes a global priority.

A recent catalyst for Thrive Tribe’s surge has been its progress in developing innovative security technologies and potential new partnerships with enterprises looking to bolster their digital defences. As businesses increasingly prioritise cybersecurity investment, Thrive Tribe is well-positioned to capitalise on this growing demand.

Given the increasing frequency of cyberattacks and tightening regulatory frameworks around data protection, Thrive Tribe Technologies presents an intriguing opportunity for investors seeking ASX growth stocks with exposure to the cybersecurity sector.

Thrive Tribe Technologies has achieved a 300% share price return over the last three months.

Market cap: $689.86.

Bioxyne Ltd (ASX: BXN)

Bioxyne Ltd is a health and wellness company specialising in probiotics and immune health products. Its recent share price surge reflects growing consumer demand for natural health solutions and increasing recognition of the benefits of gut health in overall well-being.

A key factor driving Bioxyne’s growth has been its expansion into Asian markets, where demand for premium probiotic products continues to rise. The company’s strategic partnerships and ongoing product innovation have further strengthened its position in the functional health industry.

As health-conscious consumers prioritise immune support and digestive wellness, Bioxyne’s continued expansion and product development could make it a compelling choice for investors looking at ASX growth stocks in the health sector.

Bioxyne Ltd has achieved a 266.7% share price return over the last three months.

Market cap: $94.26 million.

Noviqtech (ASX: NQT)

Noviqtech is a technology-driven company specialising in artificial intelligence (AI) and data analytics solutions. Its share price has surged in recent months, fuelled by the increasing adoption of AI-driven technologies across multiple industries.

The company’s focus on delivering cutting-edge data solutions has attracted strong investor interest, particularly as businesses seek to leverage AI to optimise operations. Noviqtech’s recent product developments and strategic partnerships have further cemented its growth trajectory.

With AI adoption accelerating across sectors such as finance, healthcare, and logistics, Noviqtech is well-positioned to benefit. Investors tracking ASX growth stocks in the technology space may find this company’s upward momentum appealing.

Noviqtech has achieved a 263.6% share price return over the last three months.

Market cap: $17.04 million.

Aldoro Resources (ASX: ARN)

Aldoro Resources is a mineral exploration company focused on nickel, lithium, and rare earth elements – commodities that are crucial to the clean energy transition. Its recent share price rally has been driven by increasing demand for battery metals and significant exploration progress.

The company’s Western Australian projects, particularly its Narndee and Wyemandoo tenements, have shown promising results, sparking optimism about future resource potential. With electric vehicle and renewable energy sectors requiring vast amounts of these critical minerals, Aldoro Resources is well placed for further growth.

As global electrification trends continue, Aldoro Resources could be a compelling ASX growth stock for investors seeking exposure to the booming battery metals market.

Aldoro Resources has achieved a 229.5% share price return over the last three months.

Market cap: $52.39 million.

Cyclone Metals (ASX: CLE)

Cyclone Metals is a mineral exploration company with a focus on iron ore, copper, and other critical minerals. Its share price has surged as investors seek exposure to companies with potential large-scale resource projects in key mining regions.

The company’s growth has been fuelled by renewed interest in iron ore prices and promising exploration updates. With global infrastructure spending on the rise, Cyclone Metals stands to benefit from increased demand for raw materials, particularly as steel production remains strong.

For investors looking at ASX growth stocks in the resources sector, Cyclone Metals could be one to watch, especially as its exploration efforts continue to advance.

Cyclone Metals has achieved a 206.6% share price return over the last three months.

Market cap: $57.50 million.

Singular Health Group (ASX: SHG)

Singular Health Group is a medtech company specialising in 3D medical imaging and AI-powered diagnostic tools. Its recent share price rally has been driven by growing demand for advanced healthcare technology solutions that enhance patient outcomes.

The company’s success has been bolstered by strategic partnerships with healthcare providers and the expansion of its software solutions. As the healthcare industry continues to adopt AI and digital innovations, Singular Health Group is well-positioned to grow.

For investors seeking exposure to high-growth medtech companies, Singular Health’s progress in AI-driven diagnostics makes it a compelling ASX growth stock to monitor.

Singular Health Group has achieved a 201.2% share price return over the last three months.

Market cap: $64.23 million.

Wellard Ltd (ASX: WLD)

Wellard Ltd is an agribusiness company focused on livestock exports and supply chain logistics. Its share price rise has been supported by strong demand for Australian livestock in international markets and improved operational efficiencies.

The company has benefited from favourable trade agreements and increasing global meat consumption. As a key player in livestock exports, Wellard continues to expand its market reach and optimise its supply chain.

For investors looking at ASX growth stocks in the agricultural sector, Wellard’s strategic positioning and export potential make it an interesting stock to watch.

Wellard Ltd has achieved a 196.8% share price return over the last three months.

Market cap: $78.63 million.

How to trade ASX Growth Stocks

Take your position on over 13,000 local and international shares via CFDs or share trading – all at your fingertips on our award-winning platform.*

Learn more about share CFDs or share trading with us, or open an account to get started today.

* Best Finance App, Best Multi-Platform Provider and Best Platform for the Active Trader as awarded at the ADVFN International Financial Awards 2024.

This information has been prepared by IG, a trading name of IG Australia Pty Ltd. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get commission from just 0.08% on major global shares
  • Trade CFDs straight into order books with direct market access

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.